1 year return (CAGR)
-78.82%
Dermata Therapeutics Inc Exchange (NASDAQ, USD)
DRMA
1.15
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-81.29%
5 year return (CAGR)
-83.83%
10 year return (CAGR)
16.96%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
5.70M
Price/Sales
-
Ent value
3.12M
Price/Book
1.63
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-73.79%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.18 |
| Daily high | 1.19 |
| Daily low | 1.15 |
| Daily Volume | 26K |
| All-time high | 1500000.00 |
| 1y analyst estimate | 4.00 |
| Beta | 0.66 |
| EPS (TTM) | -2.08 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| DRMA | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.58% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 22 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -83.84% | -10.68% |
| Avg time to new high | 97 days | 12 days |
| Max time to new high | 1519 days | 1805 days |
News
